⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

March 3, 2015Platelets

Characterization of UBO-QIC as a Gαqinhibitor in platelets

View Full Paper

Ask AI

Bookmark

Share

Authors

VIVaishali V. InamdarCape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa APAkruti PatelUniversity of Louisville BMBhanu Kanth ManneUniversity of Utah

Discussion

Loading...

Member takes

Implication

Alternative Gαq inhibitor may enable continued platelet research; leaves open clinical translation.

Key Points

Key points are not available for this paper at this time.

Cite This Study

Inamdar et al. (2015) studied this question.

synapsesocial.com/papers/6a6faeeb26a7f98052dc4ca6 https://doi.org/10.3109/09537104.2014.998993

Topics

Dual antiplatelet therapy

View Full Paper

Ask AI

Bookmark

Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Biological properties of a specific G<i>α</i><sub>q/11</sub> inhibitor, YM‐254890, on platelet functions and thrombus formation under high‐shear stress2006 · 65 citations
2Coordinated Signaling through Both G12/13 and Gi Pathways Is Sufficient to Activate GPIIb/IIIa in Human Platelets2002 · 124 citations
3The role of ADP receptors in platelet function2006 · 197 citations
4Phosphorylation of the vasodilator-stimulated phosphoprotein (VASP) by the anti-platelet drug, cilostazol, in platelets2003 · 106 citations
5Role of platelets in thrombosis and hemostasis1994 · 217 citations